Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol. | Cancers (Basel) | 2023 | 37297025 | PubTator, text mining | PubMed |
| Characterization of extensive 2-fluorodeschloroketamine metabolism in pooled human liver microsomes, urine and hair from an addicted patient using high-resolution accurate mass spectrometry. | J Anal Toxicol | 2023 | 37279563 | PubTator, text mining | PubMed |
| Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value. | Mol Ther Methods Clin Dev | 2023 | 37273899 | PubTator, text mining | PubMed |
| Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell-cell interactions. | Commun Biol | 2023 | 37264057 | PubTator, text mining | PubMed |
| The circadian clock is disrupted in pancreatic cancer. | PLoS Genet | 2023 | 37262074 | PubTator, text mining | PubMed |
| LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944. | Pharmaceuticals (Basel) | 2023 | 37259332 | PubTator, text mining | PubMed |
| From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. | Nat Commun | 2023 | 37248212 | PubTator, text mining | PubMed |
| Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration. | Life (Basel) | 2023 | 37240761 | PubTator, text mining | PubMed |
| Understanding and targeting resistance mechanisms in cancer. | MedComm (2020) | 2023 | 37229486 | PubTator, text mining | PubMed |
| Effect of modified clivoaxial angle on surgical decision making and treatment outcomes in patients with Chiari malformation type 1. | Front Surg | 2023 | 37215352 | PubTator, text mining | PubMed |
| Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas. | Clin Epigenetics | 2023 | 37208732 | PubTator, text mining | PubMed |
| Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia. | Cancer Cell Int | 2023 | 37208719 | PubTator, text mining | PubMed |
| Risk and Severity of COVID-19 Infection in Monoclonal Gammopathy of Undetermined Significance: A 3-Year Propensity Matched Cohort Study. | Clin Lymphoma Myeloma Leuk | 2023 | 37208255 | PubTator, text mining | PubMed |
| Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma. | J Gastrointest Oncol | 2023 | 37201091 | PubTator, text mining | PubMed |
| Combination of Tissue Microarray Profiling and Multiplexed IHC Approaches to Investigate Transport Mechanism of Nucleoside Analog Drug Resistance. | Methods Mol Biol | 2023 | 37191793 | PubTator, text mining | PubMed |
| What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach. | Cancers (Basel) | 2023 | 37190176 | PubTator, text mining | PubMed |
| Fluorinated carbohydrates for 18F-positron emission tomography (PET). | Chem Soc Rev | 2023 | 37171037 | PubTator, text mining | PubMed |
| Targeting the nucleotide metabolism of Trypanosoma brucei and other trypanosomatids. | FEMS Microbiol Rev | 2023 | 37156497 | PubTator, text mining | PubMed |
| Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling. | J Cancer | 2023 | 37151398 | PubTator, text mining | PubMed |
| Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies. | Front Cell Dev Biol | 2023 | 37143892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=8